Bio-Rad Laboratories Return on Tangible Equity 2010-2023 | BIO
Bio-Rad Laboratories Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2023-12-31 | $-0.64B | $8.01B | -7.86% |
2023-09-30 | $-0.16B | $7.70B | -1.91% |
2023-06-30 | $-0.43B | $7.71B | -5.13% |
2023-03-31 | $-0.19B | $9.03B | -2.25% |
2022-12-31 | $-3.63B | $8.88B | -42.01% |
2022-09-30 | $-6.02B | $7.73B | -62.16% |
2022-06-30 | $-1.93B | $8.34B | -16.82% |
2022-03-31 | $-0.09B | $9.59B | -0.74% |
2021-12-31 | $4.25B | $13.08B | 34.59% |
2021-09-30 | $6.67B | $14.86B | 58.61% |
2021-06-30 | $4.05B | $11.12B | 41.61% |
2021-03-31 | $4.11B | $10.13B | 47.33% |
2020-12-31 | $3.81B | $9.39B | 50.09% |
2020-09-30 | $3.52B | $8.33B | 53.30% |
2020-06-30 | $1.95B | $6.85B | 34.13% |
2020-03-31 | $1.58B | $5.89B | 29.96% |
2019-12-31 | $1.76B | $5.35B | 35.73% |
2019-09-30 | $0.38B | $4.72B | 8.35% |
2019-06-30 | $0.90B | $5.12B | 20.62% |
2019-03-31 | $0.57B | $4.49B | 13.98% |
2018-12-31 | $0.37B | $3.67B | 9.30% |
2018-09-30 | $1.28B | $4.25B | 35.75% |
2018-06-30 | $1.03B | $3.98B | 33.80% |
2018-03-31 | $0.77B | $3.81B | 29.78% |
2017-12-31 | $0.12B | $2.25B | 5.75% |
2017-09-30 | $0.02B | $2.15B | 0.78% |
2017-06-30 | $0.01B | $2.10B | 0.60% |
2017-03-31 | $0.03B | $2.00B | 1.28% |
2016-12-31 | $0.03B | $1.94B | 1.32% |
2016-09-30 | $0.09B | $1.98B | 5.06% |
2016-06-30 | $0.09B | $1.88B | 5.20% |
2016-03-31 | $0.10B | $1.79B | 5.99% |
2015-12-31 | $0.11B | $1.78B | 6.67% |
2015-09-30 | $0.10B | $1.70B | 6.59% |
2015-06-30 | $0.10B | $1.61B | 6.60% |
2015-03-31 | $0.10B | $1.45B | 7.10% |
2014-12-31 | $0.09B | $1.43B | 6.32% |
2014-09-30 | $0.08B | $1.39B | 5.71% |
2014-06-30 | $0.06B | $1.42B | 4.42% |
2014-03-31 | $0.07B | $1.46B | 4.74% |
2013-12-31 | $0.08B | $1.40B | 5.92% |
2013-09-30 | $0.09B | $1.33B | 7.10% |
2013-06-30 | $0.14B | $1.29B | 11.35% |
2013-03-31 | $0.15B | $1.24B | 12.77% |
2012-12-31 | $0.17B | $1.26B | 14.09% |
2012-09-30 | $0.18B | $1.18B | 16.40% |
2012-06-30 | $0.19B | $1.15B | 16.80% |
2012-03-31 | $0.18B | $1.10B | 16.12% |
2011-12-31 | $0.18B | $1.02B | 16.52% |
2011-09-30 | $0.19B | $1.14B | 17.43% |
2011-06-30 | $0.19B | $1.13B | 18.51% |
2011-03-31 | $0.18B | $1.05B | 20.10% |
2010-12-31 | $0.19B | $0.97B | 22.09% |
2010-09-30 | $0.16B | $0.87B | 19.86% |
2010-06-30 | $0.15B | $0.77B | 20.30% |
2010-03-31 | $0.15B | $0.75B | 21.61% |
2009-12-31 | $0.15B | $0.75B | 22.62% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $7.869B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
Stryker (SYK) | United States | $127.690B | 31.66 |
Boston Scientific (BSX) | United States | $107.347B | 34.19 |
Medtronic (MDT) | Ireland | $105.881B | 14.99 |
EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
ResMed (RMD) | United States | $32.074B | 30.08 |
Terumo (TRUMY) | Japan | $24.746B | 34.95 |
Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
Baxter (BAX) | United States | $20.379B | 14.86 |
Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
Insulet (PODD) | United States | $11.637B | 61.10 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
Haemonetics (HAE) | United States | $4.621B | 23.63 |
Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
Envista Holdings (NVST) | United States | $3.504B | 13.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
Neogen (NEOG) | United States | $2.630B | 25.29 |
Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
ICU Medical (ICUI) | United States | $2.311B | 17.24 |
TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
Owens & Minor (OMI) | United States | $1.922B | 18.45 |
Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
InMode (INMD) | Israel | $1.439B | 7.45 |
National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
Warby Parker (WRBY) | United States | $1.271B | 0.00 |
AtriCure (ATRC) | United States | $1.121B | 0.00 |
MacroGenics (MGNX) | United States | $0.911B | 0.00 |
Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
Evolus (EOLS) | United States | $0.662B | 0.00 |
Jin Medical (ZJYL) | China | $0.626B | 0.00 |
Quanterix (QTRX) | United States | $0.595B | 0.00 |
Valneva SE (VALN) | France | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
PetIQ (PETQ) | United States | $0.486B | 18.16 |
TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
ZimVie (ZIMV) | United States | $0.431B | 26.37 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
Zynex (ZYXI) | United States | $0.361B | 41.52 |
Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
Cerus (CERS) | United States | $0.310B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
InterCure (INCR) | Israel | $0.121B | 20.46 |
Fonar (FONR) | United States | $0.103B | 8.84 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Chimerix (CMRX) | United States | $0.080B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.77 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |